ICON completed the acquisition of MedPass International.

ICON, a provider of drug and device development and commercialization services to the pharmaceutical industry, completed the acquisition of MedPass International, a medical device CRO and regulatory and reimbursement consultancy. Financial terms were not disclosed. “As the leader in Medical Device Regulation and Clinical Development in Europe, MedPass is delighted to be joining ICON to become the global service provider of choice in Medtech Devices and Diagnostics,” Sarah Sorrell, MedPass President and CEO.